scholarly journals Long-term follow-up of whole lung lavage in patients with pulmonary alveolar proteinosis

2014 ◽  
Vol 8 (3) ◽  
pp. 763-768 ◽  
Author(s):  
XIAOYAN ZHOU ◽  
GUOCHU LU ◽  
ZHEN YU ◽  
FEI GAO ◽  
TAO BIAN
2014 ◽  
Vol 13 (3) ◽  
pp. 6135-6141 ◽  
Author(s):  
F. Gao ◽  
G.C. Lu ◽  
X.Y. Zhou ◽  
Z. Yu ◽  
H.M. Wang ◽  
...  

2021 ◽  
Vol 15 (1) ◽  
Author(s):  
Abdalla Mohmed Alasiri ◽  
Reem Abdullah Alasbali ◽  
Meaad Ali Alaqil ◽  
Aishah Marei Alahmari ◽  
Nouf Dagash Alshamrani ◽  
...  

Abstract Background Pulmonary alveolar proteinosis is a rare interstitial lung disease characterized by accumulating surfactant materials in the alveoli. The autoimmune form is by far the most common in adults, while in the pediatric age group, the vast majority of cases are congenital. We report a case of an adolescent patient diagnosed with autoimmune pulmonary alveolar proteinosis, which is unusual in this age group. Case presentation A-15 year-old Saudi male presented to the emergency department with a history of shortness of breath and low oxygen saturation. High-resolution computed tomography of his chest showed a global crazy-paving pattern. Autoantibodies against granulocyte-macrophage colony-stimulating factor were detected in his serum. A diagnosis of the autoimmune form of pulmonary alveolar proteinosis was confirmed after excluding other possible causes. The patient improved after he underwent whole lung lavage under general anesthesia, and he was independent of oxygen therapy after 6 months of follow-up. Conclusion The autoimmune form of pulmonary alveolar proteinosis is rare in the pediatric age group and should be considered when no apparent cause of this disease was found. Whole lung lavage should be the first treatment modality offered in this setting with close follow-up and monitoring.


2004 ◽  
Vol 23 (4) ◽  
pp. 526-531 ◽  
Author(s):  
M. Beccaria ◽  
M. Luisetti ◽  
G. Rodi ◽  
A. Corsico ◽  
M.C. Zoia ◽  
...  

2021 ◽  
Vol 49 (4) ◽  
pp. 030006052110100
Author(s):  
Shenyun Shi ◽  
Rujia Wang ◽  
Ling Chen ◽  
Yan Li ◽  
Yingwei Zhang ◽  
...  

Pulmonary alveolar proteinosis (PAP) is a rare disorder characterized by the accumulation of excessive surfactant lipids and proteins in alveolar macrophages and alveoli. Oral statin therapy is a novel treatment for PAP with hypercholesterolemia. However, this treatment has never been described in a patient without hypercholesterolemia. Here, we present a case of successful treatment with atorvastatin for a patient with possibly unclassified PAP without hypercholesterolemia who responded poorly to whole lung lavage therapy and inhaled granulocyte-macrophage colony-stimulating factor. After 18 months of atorvastatin treatment, the patient experienced improvements in dyspnea, radiographic abnormalities and pulmonary function. The present case study supports the feasibility of statin therapy for PAP regardless of the level of cholesterol.


2020 ◽  
Vol 90 (5) ◽  
pp. 877-878
Author(s):  
Tovi Vo ◽  
Justin C. Y. Chan ◽  
Michael Worthington

2012 ◽  
Vol 88 (1042) ◽  
pp. 492-493 ◽  
Author(s):  
Chang Cai ◽  
Min Ye ◽  
Honglei Xu ◽  
Yuping Li

CHEST Journal ◽  
2021 ◽  
Vol 160 (4) ◽  
pp. A1171
Author(s):  
Paula D'Ambrosio ◽  
Philippe Colares ◽  
Pedro Ciaralo ◽  
HÉLIO MINAMOTO ◽  
Ronaldo Kairalla

Sign in / Sign up

Export Citation Format

Share Document